Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.870
-0.100 (-5.08%)
At close: Mar 20, 2026, 4:00 PM EDT
1.880
+0.010 (0.53%)
After-hours: Mar 20, 2026, 7:34 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $180.71 million as of March 20, 2026. Its market cap has increased by 72.04% in one year.
Market Cap
180.71M
Enterprise Value
65.09M
1-Year Change
72.04%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $180.71M, a decrease of -79.66%. That is a compound annual growth rate of -28.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 180.71M | 21.60% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prelude Therapeutics | 200.98M |
| Compugen | 199.51M |
| SAB Biotherapeutics | 192.59M |
| Arcturus Therapeutics Holdings | 191.00M |
| Zentalis Pharmaceuticals | 184.96M |
| MacroGenics | 184.31M |
| Cibus | 184.06M |
| NeOnc Technologies Holdings | 181.54M |